190 related articles for article (PubMed ID: 38644417)
1. A dynamic computational model of the parallel circuit on the basal ganglia-cortex associated with Parkinson's disease dementia.
Yang H; Yang X; Yan S
Biol Cybern; 2024 Apr; 118(1-2):127-143. PubMed ID: 38644417
[TBL] [Abstract][Full Text] [Related]
2. Functional segregation of basal ganglia pathways in Parkinson's disease.
Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
[TBL] [Abstract][Full Text] [Related]
3. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
Braak H; Del Tredici K
Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
[TBL] [Abstract][Full Text] [Related]
4. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
5. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?
Helmich RC; Hallett M; Deuschl G; Toni I; Bloem BR
Brain; 2012 Nov; 135(Pt 11):3206-26. PubMed ID: 22382359
[TBL] [Abstract][Full Text] [Related]
6. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus.
Dirkx MF; den Ouden HE; Aarts E; Timmer MH; Bloem BR; Toni I; Helmich RC
Brain; 2017 Mar; 140(3):721-734. PubMed ID: 28073788
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease dementia: a neural networks perspective.
Gratwicke J; Jahanshahi M; Foltynie T
Brain; 2015 Jun; 138(Pt 6):1454-76. PubMed ID: 25888551
[TBL] [Abstract][Full Text] [Related]
8. Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson's disease: pathophysiology or compensation?
Martinu K; Monchi O
Behav Neurosci; 2013 Apr; 127(2):222-36. PubMed ID: 23244290
[TBL] [Abstract][Full Text] [Related]
9. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
10. Functional neuropathology in Parkinson's disease.
Gibb WR
Eur Neurol; 1997; 38 Suppl 2():21-5. PubMed ID: 9387799
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
Hirano S
Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
[TBL] [Abstract][Full Text] [Related]
12. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory.
Marklund P; Larsson A; Elgh E; Linder J; Riklund KA; Forsgren L; Nyberg L
Brain; 2009 Feb; 132(Pt 2):336-46. PubMed ID: 19036762
[TBL] [Abstract][Full Text] [Related]
13. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
15. Neural correlates underlying micrographia in Parkinson's disease.
Wu T; Zhang J; Hallett M; Feng T; Hou Y; Chan P
Brain; 2016 Jan; 139(Pt 1):144-60. PubMed ID: 26525918
[TBL] [Abstract][Full Text] [Related]
16. Multi-timescale neuromodulation strategy for closed-loop deep brain stimulation in Parkinson's disease.
Quan Z; Li Y; Wang S
J Neural Eng; 2024 May; 21(3):. PubMed ID: 38653252
[No Abstract] [Full Text] [Related]
17. Reduced topological efficiency in cortical-basal Ganglia motor network of Parkinson's disease: a resting state fMRI study.
Wei L; Zhang J; Long Z; Wu GR; Hu X; Zhang Y; Wang J
PLoS One; 2014; 9(10):e108124. PubMed ID: 25279557
[TBL] [Abstract][Full Text] [Related]
18. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's disease.
Cai W; Young CB; Yuan R; Lee B; Ryman S; Kim J; Yang L; Henderson VW; Poston KL; Menon V
Brain; 2022 Nov; 145(11):4042-4055. PubMed ID: 35357463
[TBL] [Abstract][Full Text] [Related]
20. Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia.
Leblois A; Boraud T; Meissner W; Bergman H; Hansel D
J Neurosci; 2006 Mar; 26(13):3567-83. PubMed ID: 16571765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
